Oncoclínicas Group generated record earnings in the second quarter of 2023, R$309 million and a net profit of R$35 million
- Written by PR Newswire
Efficient management of working capital explains a large part of the cash flow performance. Net income grew 51% (31% organically) while the Ebitda Ex-LTIP (excluding only the non-cash impact of the long-term incentive plan) reached R$268 million, 109% greater than the same period last year
SÃO PAULO, August 16, 2023 /PRNewswire/ -- Oncocl&iac...














